A clinically relevant population of leukemic CD34(+)CD38(−) cells in acute myeloid leukemia

Relapse of acute myeloid leukemia (AML) is thought to reflect the failure of current therapies to adequately target leukemia stem cells (LSCs), the rare, resistant cells presumed responsible for maintenance of the leukemia and typically enriched in the CD34(+)CD38(−) cell population. Despite the con...

詳細記述

保存先:
書誌詳細
主要な著者: Gerber, Jonathan M., Smith, B. Douglas, Ngwang, Brownhilda, Zhang, Hao, Vala, Milada S., Morsberger, Laura, Galkin, Steven, Collector, Michael I., Perkins, Brandy, Levis, Mark J., Griffin, Constance A., Sharkis, Saul J., Borowitz, Michael J., Karp, Judith E., Jones, Richard J.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2012
主題:
Myeloid Neoplasia
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325044/
https://ncbi.nlm.nih.gov/pubmed/22262762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-06-364182
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料